1,4-Dimethylpiperazine-2,5-dione

Catalog No. :
ACLYHC756
CAS No. :
5076-82-4
Molecular Formula :
C6H10N2O2
Molecular Weight :
142.16

IUPAC Name:1,4-dimethylpiperazine-2,5-dione

1,4-Dimethylpiperazine-2,5-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$114.00Login to see priceInquiryInquiry
25g95%$474.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4-Dimethylpiperazine-2,5-dione
IUPAC Name1,4-dimethylpiperazine-2,5-dione
MDL No.MFCD00006519
Molecular FormulaC6H10N2O2
Molecular Weight142.16
SMILESO=C1N(CC(N(C1)C)=O)C
InChI KeyPKDGRAULLDDTRN-UHFFFAOYSA-N
Synonym1,4-Dimethyl-2,5-dioxopiperazine | Sarcosine anhydride | 1,4-Dimethyl-2,5-piperazinedione | Sarcosine anhydride, bimol. cyclic; Sarcosine diketopiperazine | Cyclo(sarcosylsarcosyl) | NSC 67461 | AC-907/25014144 | Sarcosine anhydride, 99% | DTXSID20198796
CAS No.5076-82-4
PubChem CID78761

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLYHC756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAHQU671 route compound structure diagram
    ACAHQU6715888-91-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACLYHC756 route product structure diagram
    ACLYHC7565076-82-4
Inquiry

2. ACLYHC756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXLGZ502 route compound structure diagram
    ACXLGZ5025625-52-5 In Stock
  4. Then
  5. ACLYHC756 route product structure diagram
    ACLYHC7565076-82-4
Inquiry

Comments (0)